Serial biotech founder George Church has a new startup, and this time, he has skin in the game, quite literally.

Skin care has a new biotech player. Debut, an incubator that has raised more than $70 million in funding thanks in part to a $40 million series B Round led last fall by L'Oréal's Bold venture ...

Genoskin is a company that has figured out how to keep human skin alive for up to a week away from the body, and is using their tech to provide testing samples to the biotech, pharmaceutical and ...

Renowned Harvard geneticist and serial entrepreneur George Church is at it again, with a venture that has raised $75 million ...

The Federal Reserve yesterday cut interest rates by 50 basis points, in its first time cutting rates in four years. And how ...

Selling plaque psoriasis drug Vtama to Organon looks like another win for Roivant, which has been buying overlooked drugs, ...

Evonik has developed a groundbreaking model of the skin microbiome that allows for realistic, scientifically validated ...

Vanda Pharmaceuticals has failed to persuade the FDA to approve its gastroparesis candidate on the strength of a phase 3 ...

GC Therapeutics has entered gameplay with the mission of unlocking a new generation of cell therapies, uploading with $75 ...

The global skincare market is set for substantial growth, with an estimated valuation of USD 166,870.4 million in 2024.

Alteogen overtakes EcoPro BM, South Korea’s largest producer of cathodes for EV batteries, to become the biggest company on the Kosdaq by market capitalization.

The Thioglycolate market is estimated to be valued at USD 152.7 million in 2024. The market is anticipated to reach USD 364.3 ...